CPC C07C 69/757 (2013.01) [A61P 25/00 (2018.01); C07C 59/54 (2013.01); C07C 59/56 (2013.01); C07C 69/732 (2013.01)] | 19 Claims |
1. A compound according to formula I
![]() or a pharmaceutically acceptance salt thereof, wherein:
i) R5 is H, R1 and R2 form a ring system, and said compound is selected from:
![]() or a compound of formula IV:
![]() wherein:
n is 1;
X is selected from O and NH
Y is selected from NH, O, and CH2
R3 is selected from H, linear or branched C1-C6 alkyl, benzyl, polyethylenglycolyl,
![]() R9 is selected from linear and branched C1-C6 alkyl;
R10 is selected from H, -Me, -Et, —Pr, -iPr, -Bu, -iBu, -tBu, pentyl, neopentyl, and hexyl;
R4 is selected from H, —C(═O)—C1-C6-alkyl; —C(═O)-benzyl, polyethylenglycolyl,
![]() R11 is selected from linear and branched C1-C6 alkyl;
each instance of
![]() R12 is selected from H, -Me, -Et, —Pr, -iPr, -Bu, -iBu, -tBu, pentyl, neopentyl, and hexyl;
R6 and R7 are each independently selected from H, F, Cl, Br, I, aryl, straight linear or branched C1-8 alkyl, —CH2(CH2)p-aryl, —CH═CH-aryl, NH2, NO2, OH, SH, linear or branched —O—C1-8 alkyl, linear or branched —S—C1-8 alkyl, linear or branched —NH—C1-8 alkyl, —O-aryl, —S-aryl, and —NH-aryl;
wherein aryl optionally includes one or more heteroatoms selected from O, N and S; and
wherein p is 0 or 1; or
ii) R2 is H, R1 and R5 form a ring system, and said compound is a compound of formula IIIb, formula IIIc, or formula IIId:
![]() wherein:
n is 0 or 1;
X is selected from O and NH;
m is 0 or 1;
R3 is selected from H, linear or branched C1-C6-alkyl; -benzyl, polyethylenglycolyl,
![]() R9 is selected from linear and branched C1-C6 alkyl;
R10 is selected from H, -Me, -Et, —Pr, -iPr, -Bu, -iBu, -tBu, pentyl, neopentyl, and hexyl;
R4 is selected from H, —C(═O)—C1-C6-alkyl; —C(═O)-benzyl, polyethylenglycolyl,
![]() each instance of
![]() R1 is selected from linear and branched C1-C6 alkyl; R12 is selected from H, -Me, -Et, —Pr, -iPr, -Bu, -iBu, -tBu, pentyl, neopentyl, and hexyl;
R13, is selected from H, F, Br, aryl, linear or branched C1-8 alkyl, —CH2(CH2)p-aryl, —CH═CH-aryl, NH2, NO2, OH, SH, linear or branched —O—C2-8 alkyl, linear or branched —S—C1-8 alkyl, linear or branched —NH—C1-8 alkyl, —O-aryl, —S-aryl, and —NH-aryl,
R14 is selected from H, F, Cl, Br, aryl, linear or branched C1-8 alkyl, —CH2(CH2)p-aryl, —CH═CH-aryl, NH2, OH, SH, linear or branched —O—C1-8 alkyl, linear or branched —S—C1-8 alkyl, linear or branched —NH—C1-8 alkyl, —O-aryl, —S-aryl, and —NH-aryl,
each aryl optionally includes one or more heteroatoms selected from O, N and S, and wherein each instance of p is independently 0 or 1;
with the proviso that the compounds of formula IV, when R4 is H or H3 or CH3, then:
i) R6 and R7 are not both Cl,
ii) R6 and R7 are not both methyl,
iii) when R6 is Cl then R7 is not F, and
iv) when R6 is F then R7 is not Cl . . .
![]() |